Cancer statistics, CA Cancer J Clin. févr, vol.64, issue.1, pp.9-29, 2014. ,
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT), Lancet. 2 avr, vol.387, pp.1415-1441, 2016. ,
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions, Clin Respir J. 28 févr, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-02000328
Interventional therapies for malignant pleural effusions: the present and the future, Respirology. août, vol.19, issue.6, pp.809-831, 2014. ,
BTS Pleural Disease Guideline Group. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline, Thorax. août, vol.65, issue.2, pp.32-40, 2010. ,
Clinical features and survival of lung cancer patients with pleural effusions, Respirology. mai, vol.20, issue.4, pp.654-663, 2015. ,
Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score, Thorax. déc, vol.69, issue.12, pp.1098-104, 2014. ,
ERS/EACTS statement on the management of malignant pleural effusions, Eur Respir J. juill, vol.52, issue.1, 2018. ,
Management of malignant pleural effusions: questions that need answers, Curr Opin Pulm Med. juill, vol.19, issue.4, pp.374-383, 2013. ,
Comparing approaches to the management of malignant pleural effusions, Expert Rev Respir Med, vol.11, issue.4, pp.273-84, 2017. ,
Tunneled pleural catheters: an update for 2013, Clin Chest Med. mars, vol.34, issue.1, pp.73-80, 2013. ,
Interventions for the management of malignant pleural effusions: a network meta-analysis, Cochrane Database Syst Rev. 8 mai, issue.5, p.10529, 2016. ,
Tumor type influences the effectiveness of pleurodesis in malignant effusions, Respiration, vol.189, issue.2, pp.91-99, 2011. ,
Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis, vol.3, p.254, 2014. ,
Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion, Chest. mars, vol.127, issue.3, pp.909-924, 2005. ,
Evaluating the efficacy of thoracoscopy and talc poudrage versus pleurodesis using talc slurry (TAPPS trial): protocol of an open-label randomised controlled trial, BMJ Open, vol.4, issue.11, p.7045, 2014. ,
Identification of clinical factors predicting Pleurx catheter removal in patients treated for malignant pleural effusion, Eur J Cardiothorac Surg. janv, vol.33, issue.1, pp.89-94, 2008. ,
Single-center experience with 250 tunnelled pleural catheter insertions for malignant pleural effusion, Chest. févr, vol.129, issue.2, pp.362-370, 2006. ,
Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial, JAMA. 13 juin, vol.307, issue.22, pp.2383-2392, 2012. ,
Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial, JAMA, vol.21, pp.1903-1915, 2017. ,
An alternative splicing product of the lamin A/C gene lacks exon 10, J Biol Chem. 19 avr, vol.271, issue.16, pp.9249-53, 1996. ,
Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C, J Biol Chem. 5 août, vol.268, issue.22, pp.16321-16327, 1993. ,
Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin, Genes Dev. 1 avr, vol.22, issue.7, pp.832-53, 2008. ,
Nuclear matrix, nuclear envelope and premature aging syndromes in a translational research perspective, Semin Cell Dev Biol. mai, vol.29, pp.125-172, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01646524
Nuclear lamins: laminopathies and their role in premature ageing, Physiol Rev. juill, vol.86, issue.3, pp.967-1008, 2006. ,
Use of a general purpose mammalian expression vector for studying intracellular protein targeting: identification of critical residues in the nuclear lamin A/C nuclear localization signal, J Cell Sci. juin, vol.105, issue.2, pp.481-489, 1993. ,
Nuclear lamins: their structure, assembly, and interactions, J Struct Biol, vol.122, issue.1-2, pp.42-66, 1998. ,
Functional organization of the nuclear envelope, Annu Rev Cell Biol, vol.4, pp.335-74, 1988. ,
The nuclear lamins. A multigene family of proteins in evolution and differentiation, Exp Cell Res. janv, vol.162, issue.1, pp.1-10, 1986. ,
Assembly and cell cycle dynamics of the nuclear lamina, Semin Cell Biol. août, vol.3, issue.4, pp.245-53, 1992. ,
Nuclear lamins in cancer, Cell Mol Bioeng. juin, vol.9, issue.2, pp.258-67, 2016. ,
Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation, Science. 30 août, vol.341, issue.6149, p.1240104, 2013. ,
Nuclear lamin functions and disease, Trends Genet. sept, vol.28, issue.9, pp.464-71, 2012. ,
Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction, J Clin Invest. févr, vol.113, issue.3, pp.370-378, 2004. ,
Lamins A and C but not lamin B1 regulate nuclear mechanics, J Biol Chem. 1 sept, vol.281, issue.35, pp.25768-80, 2006. ,
Mechanisms and functions of nuclear envelope remodelling, Nat Rev Mol Cell Biol. avr, vol.18, issue.4, pp.229-274, 2017. ,
A dual role for A-type lamins in DNA double-strand break repair, Cell Cycle. 1 août, vol.10, issue.15, pp.2549-60, 2011. ,
Regulation of nucleotide excision repair by nuclear lamin b1, PLoS ONE, vol.8, issue.7, p.69169, 2013. ,
A-type lamins maintain the positional stability of DNA damage repair foci in mammalian nuclei, PLoS ONE, vol.8, issue.5, p.61893, 2013. ,
The role of the nuclear lamina in cancer and apoptosis, Adv Exp Med Biol, vol.773, pp.27-48, 2014. ,
Shared molecular and cellular mechanisms of premature ageing and ageing-associated diseases, Nat Rev Mol Cell Biol, vol.18, issue.10, pp.595-609, 2017. ,
Lamin a truncation in Hutchinson-Gilford progeria, Science. 27 juin, vol.300, issue.5628, p.2055, 2003. ,
Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome, Nature. 15 mai, vol.423, issue.6937, pp.293-301, 2003. ,
An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome, Nucleus. 1 janv, vol.9, issue.1, pp.246-57, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01774301
Transformation resistance in a premature aging disorder identifies a tumor-protective function of BRD4. Cell Rep, vol.9, pp.248-60, 2014. ,
Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer, Chin J Cancer. juin, vol.30, issue.6, pp.415-440, 2011. ,
Nuclear structure in cancer cells, Nat Rev Cancer. sept, vol.4, issue.9, pp.677-87, 2004. ,
A Novel Role of Lamins from Genetic Disease to Cancer Biomarkers, Oncol Rev, vol.10, issue.2, p.309, 2016. ,
Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence, Eur J Cancer. août, vol.47, issue.12, pp.1837-1882, 2011. ,
Loss of lamin A but not lamin C expression in epithelial ovarian cancer cells is associated with metastasis and poor prognosis, Pathol Res Pract. févr, vol.211, issue.2, pp.175-82, 2015. ,
Global loss of a nuclear lamina component, lamin A/C, and LINC complex components SUN1, SUN2, and nesprin-2 in breast cancer, Cancer Med. oct, vol.4, issue.10, pp.1547-57, 2015. ,
Differential Predictive Roles of A-and B-Type Nuclear Lamins in Prostate Cancer Progression, PLoS ONE, vol.10, issue.10, p.140671, 2015. ,
Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway, Carcinogenesis. avr, vol.33, issue.4, pp.751-760, 2012. ,
Prognostic role of NF-YA splicing isoforms and Lamin A status in low grade endometrial cancer, Oncotarget. 31 janv, vol.8, issue.5, pp.7935-7980, 2017. ,
A-and B-type lamins are differentially expressed in normal human tissues, Histochem Cell Biol. juin, vol.107, issue.6, pp.505-522, 1997. ,
Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines, Cancer Res. 15 janv, vol.51, issue.2, pp.581-587, 1991. ,
Nuclear A-type lamins are differentially expressed in human lung cancer subtypes, Am J Pathol. juill, vol.143, issue.1, pp.211-231, 1993. ,
Abnormal Atype lamin organization in a human lung carcinoma cell line, Eur J Cell Biol. août, vol.67, issue.4, pp.328-363, 1995. ,
Low lamin A expression in lung adenocarcinoma cells from pleural effusions is a pejorative factor associated with high number of metastatic sites and poor Performance status, PLoS ONE, vol.12, issue.8, p.183136, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01597882
IGF-1-induced epithelial-mesenchymal transition in MCF-7 cells is mediated by MUC1. Cell Signal, vol.26, pp.2131-2138, 2014. ,
Muc1: a multifaceted oncoprotein with a key role in cancer progression, Trends Mol Med. juin, vol.20, issue.6, pp.332-374, 2014. ,
A-type lamins: guardians of the soma?, Nat Cell Biol, vol.6, issue.11, pp.1062-1069, 2004. ,
Viscoelastic properties of the cell nucleus, Biochem Biophys Res Commun. 24 mars, vol.269, issue.3, pp.781-787, 2000. ,
Design of a microfluidic device to quantify dynamic intra-nuclear deformation during cell migration through confining environments, Integr Biol (Camb). déc, vol.7, issue.12, pp.1534-1580, 2015. ,
Role of nuclear lamins in nuclear segmentation of human neutrophils, Physiol Chem Phys Med NMR, vol.31, issue.2, pp.77-84, 1999. ,
Physical plasticity of the nucleus in stem cell differentiation, Proc Natl Acad Sci, vol.104, issue.40, pp.15619-15643, 2007. ,
Nuclear mechanics in cancer, Adv Exp Med Biol, vol.773, pp.435-70, 2014. ,
Effects of green tea extract on lung cancer A549 cells: proteomic identification of proteins associated with cell migration, Proteomics. févr, vol.9, issue.3, pp.757-67, 2009. ,
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14, Cell. 3 déc, vol.75, issue.5, pp.843-54, 1993. ,
URL : https://hal.archives-ouvertes.fr/in2p3-00597159
The nuclear RNase III Drosha initiates microRNA processing, Nature. 25 sept, vol.425, issue.6956, pp.415-424, 2003. ,
A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA, Science. 3 août, vol.293, issue.5531, pp.834-842, 2001. ,
Towards a molecular understanding of microRNA-mediated gene silencing, Nat Rev Genet. juill, vol.16, issue.7, pp.421-454, 2015. ,
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs, Nature. 17 févr, vol.433, issue.7027, pp.769-73, 2005. ,
Combinatorial microRNA target predictions, Nat Genet. mai, vol.37, issue.5, pp.495-500, 2005. ,
MicroRNA-373 induces expression of genes with complementary promoter sequences, Proc Natl Acad Sci USA. 5 févr, vol.105, issue.5, pp.1608-1621, 2008. ,
Oncomirs -microRNAs with a role in cancer, Nat Rev Cancer. avr, vol.6, issue.4, pp.259-69, 2006. ,
Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors, Invest New Drugs, vol.35, issue.2, pp.180-188, 2017. ,
Therapeutic targeting of non-coding RNAs in cancer, Biochem J. 14 déc, vol.474, issue.24, pp.4219-51, 2017. ,
Integrative analysis reveals disrupted pathways regulated by microRNAs in cancer, Nucleic Acids Res. 16 févr, vol.46, issue.3, pp.1089-101, 2018. ,
Identification of dysregulated long noncoding RNAs/microRNAs/mRNAs in TNM I stage lung adenocarcinoma, Oncotarget. 1 août, vol.8, issue.31, pp.51703-51721, 2017. ,
Identification of novel gene expression signature in lung adenocarcinoma by using next-generation sequencing data and bioinformatics analysis, Oncotarget. 1 déc, vol.8, issue.62, pp.104831-54, 2017. ,
Role of miRNAs in lung cancer, J Cell Physiol. 20 avr, 2018. ,
Critical role of miR-9 in myelopoiesis and EVI1-induced leukemogenesis, Proc Natl Acad Sci, vol.110, issue.14, pp.5594-5603, 2013. ,
A microRNA DNA methylation signature for human cancer metastasis, Proc Natl Acad Sci, vol.105, issue.36, pp.13556-61, 2008. ,
Changes in plasma miR-9, miR-16, miR-205 and miR-486 levels after non-small cell lung cancer resection, Cell Oncol (Dordr). 20 juin, 2017. ,
A microRNA expression signature of human solid tumors defines cancer gene targets, Proc Natl Acad Sci, vol.103, issue.7, pp.2257-61, 2006. ,
MicroRNA 133B targets prosurvival molecules MCL-1 and BCL2L2 in lung cancer, Biochem Biophys Res Commun, vol.388, issue.3, pp.483-492, 2009. ,
Genome-wide miRNA expression profiling identifies miR-9-3 and miR-193a as targets for DNA methylation in non-small cell lung cancers, Clin Cancer Res. 15 mars, vol.18, issue.6, pp.1619-1648, 2012. ,
Prediction of non-small cell lung cancer metastasis-associated microRNAs using bioinformatics, Am J Cancer Res, vol.5, issue.1, pp.32-51, 2015. ,
Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer, Clin Transl Oncol. mai, vol.16, issue.5, pp.469-75, 2014. ,
Small Cell Lung Cancer Screen of Oncology Drugs, Investigational Agents, and Gene and microRNA Expression, J Natl Cancer Inst, vol.108, issue.10, 2016. ,
Oncogenic miR-9 is a target of erlotinib in NSCLCs. Sci Rep, vol.5, p.17031, 2015. ,
Impact of aberrant methylation of microRNA-9 family members on non-small cell lung cancers, Mol Clin Oncol. janv, vol.1, issue.1, pp.185-194, 2013. ,
Demethylation of miR-9-3 and miR-193a genes suppresses proliferation and promotes apoptosis in non-small cell lung cancer cell lines, Cell Physiol Biochem, vol.32, issue.6, pp.1707-1726, 2013. ,
MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer, Breast Cancer Res Treat. août, vol.147, issue.1, pp.39-49, 2014. ,
miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis, Nat Cell Biol. mars, vol.12, issue.3, pp.247-56, 2010. ,
miR-9 Acts as an OncomiR in Prostate Cancer through Multiple Pathways That Drive Tumour Progression and Metastasis, PLoS ONE, vol.11, issue.7, p.159601, 2016. ,
MicroRNA-9 promotes tumor metastasis via repressing E-cadherin in esophageal squamous cell carcinoma, Oncotarget, vol.5, issue.22, pp.11669-80, 2014. ,
MicroRNA Gene Expression Signature Driven by miR-9 Overexpression in Ovarian Clear Cell Carcinoma, PLoS ONE, vol.11, issue.9, p.162584, 2016. ,
LincRNA-p21 inhibits invasion and metastasis of hepatocellular carcinoma through miR-9/E-cadherin cascade signaling pathway molecular mechanism, Onco Targets Ther, vol.10, pp.3241-3248, 2017. ,
TGF-?1-induced epithelialmesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin, Cell Mol Biol Lett, vol.22, p.22, 2017. ,
The morphogenetic role of cadherin cell adhesion molecules in human cancer: a thematic review, Cancer Invest, vol.16, issue.4, pp.252-61, 1998. ,
Cadherins and catenins in breast cancer, Curr Opin Cell Biol, vol.17, issue.5, pp.499-508, 2005. ,
Mammalian cadherins and protocadherins: about cell death, synapses and processing, Curr Opin Cell Biol, vol.17, issue.5, pp.446-52, 2005. ,
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells, J Cell Biol. avr, vol.113, issue.1, pp.173-85, 1991. ,
Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role, Cell. 12 juill, vol.66, issue.1, pp.107-126, 1991. ,
A causal role for E-cadherin in the transition from adenoma to carcinoma, Nature. 12 mars, vol.392, issue.6672, pp.190-193, 1998. ,
Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell, vol.10, pp.437-486, 2006. ,
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways, Cancer Res. 15 mai, vol.68, issue.10, pp.3645-54, 2008. ,
Btbd7 contributes to reduced E-cadherin expression and predicts poor prognosis in non-small cell lung cancer, BMC Cancer. 24 sept, vol.14, p.704, 2014. ,
Prognostic value of Twist, Snail and Ecadherin expression in pathological N0 non-small-cell lung cancer: a retrospective cohort study, Eur J Cardiothorac Surg. 5 févr, 2018. ,
E-cadherin Loss Accelerates Tumor Progression and Metastasis in a Mouse Model of Lung Adenocarcinoma, Am J Respir Cell Mol Biol. 15 févr, 2018. ,
microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus, Sci Rep, vol.3, p.2535, 2013. ,
The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells, Cancer Res. 1 févr, vol.73, issue.3, pp.1180-1189, 2013. ,
The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth, J Thorac Oncol. déc, vol.6, issue.12, pp.1984-92, 2011. ,
Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer, J Neurooncol. janv, vol.121, issue.1, pp.101-109, 2015. ,
Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer, BMC Res Notes. 6 déc, vol.6, p.518, 2013. ,
MALAT1 --a paradigm for long noncoding RNA function in cancer, J Mol Med. juill, vol.91, issue.7, pp.791-801, 2013. ,
Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA, Proc Natl Acad Sci, vol.109, issue.7, pp.423-431, 2012. ,
Unique preservation of neural cells in Hutchinson-Gilford progeria syndrome is due to the expression of the neuralspecific miR-9 microRNA, Cell Rep. 26 juill, vol.2, issue.1, pp.1-9, 2012. ,
The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation, Mol Cell. 24 sept, vol.39, issue.6, pp.925-963, 2010. ,
Lamin A-dependent nuclear defects in human aging, Science. 19 mai, vol.312, issue.5776, pp.1059-63, 2006. ,
Control of RNA processing by a large non-coding RNA over-expressed in carcinomas, FEBS Lett. 18 févr, vol.585, issue.4, pp.671-677, 2011. ,
Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer, Mol Cancer Res. sept, vol.12, issue.9, pp.1195-204, 2014. ,
The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers, J Pathol. mars, vol.229, issue.4, pp.630-639, 2013. ,
Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma, PLoS ONE, vol.7, issue.10, p.46539, 2012. ,
URL : https://hal.archives-ouvertes.fr/inserm-02337424
Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance, Nature, vol.527, issue.7579, pp.472-478, 2015. ,
Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer, Nature, vol.527, issue.7579, pp.525-555, 2015. ,